ExLibris header image
SFX Logo
Title: Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis
Source:

Scientific Reports [2045-2322] Chu, Che-Sheng yr:2018


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. White, William B. "Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout." The New England Journal of Medicine 378.13 (2018): 1200-1210. Link to SFX for this item
2. Chen, Z. "Effects of Pravastatin on neuroprotection and neurogenesis after cerebral ischemia in rats." Shen Jing Ke Xue Tong Bao （ Ying Wen Ban ） 23.4 (2007): 189-97. Link to Full Text for this item Link to SFX for this item
3. Zhang, T. "Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis." Rheumatology. 56.7: 1144-1153. Link to SFX for this item
4. Beretta, S. "Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia." Brain research 1615 (2015): 31-41. Link to SFX for this item
5. Taylor, Thomas H. "Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout: A Randomized Clinical Trial." The American journal of medicine 125.11 (2012): 1126-4294967295. Link to SFX for this item
6. Li, Q. "A strict solution for the optimal superimposition of protein structures." Acta crystallographica. Section A, Foundations of crystallography 60.Pt 3 (2004): 201-3. Link to Full Text for this item Link to SFX for this item
7. Alonso, A. "Gout, hyperuricemia, and Parkinson's disease: a protective effect?" Current Rheumatology Reports 12.2 (2010): 149-155. Link to SFX for this item
8. Wilson, Jennifer F. "Gout." Annals of Internal Medicine 152.3 (2010): 915-1. Link to SFX for this item
9. Chopp, M. "Treatment of stroke and intracerebral hemorrhage with cellular and pharmacological restorative therapies." Acta neurochirurgica. Supplementum 105.105 (2008): 79-83. Link to SFX for this item
10. Li, M. "Synthesis of gefitinib from methyl 3-hydroxy-4-methoxy-benzoate." Molecules 12.3 (2007): 673-678. Link to Full Text for this item Link to SFX for this item
11. Daimon, M. "Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces delayed neuronal death following transient forebrain ischemia in the adult rat hippocampus." Neuroscience letters (2004): 122-126. Link to SFX for this item
12. Gelber, Allan C C. "Febuxostat versus allopurinol for gout." New England Journal of Medicine, The 354.14 (2006): 1532-3. Link to SFX for this item
13. Briggs, P. Nursing standard 28.31 (2014): 21-21. Link to SFX for this item
14. Cayley, William E. "Gout." BMJ. British medical journal (Compact ed.) 341.01 (2010): 27-. Link to SFX for this item
15. Terkeltaub, Alastair L D. "Gout." The New England journal of medicine 349.17 (2003): 1647-20. Link to SFX for this item
16. Sedlacek, B. "Gout." Journal of consumer health on the Internet 16.1 (2012): 118-129. Link to SFX for this item
17. Underwood, M. "Gout." Clinical evidence 2008.13 (2006): 1561-9. Link to SFX for this item
18. Becker, Michael A A. "Febuxostat compared with allopurinol in patients with hyperuricemia and gout." The New England journal of medicine 353.23 (2005): 2450-2461. Link to SFX for this item
19. Hill, E. "Does Starting Allopurinol Prolong Acute Treated Gout? A Randomized Clinical Trial." Journal of clinical rheumatology 21.3 (2015): 120-125. Link to SFX for this item
20. Hill, E. "Does Starting Allopurinol Prolong Acute Treated Gout?" Arthritis & rheumatism 65.10 (2013). Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.